The COVID-19 pandemic catalysed the rapid deployment of digital health interventions globally, including in low- and middle-income countries (LMICs), where health systems often lacked the preparedness and infrastructure for sustained scale-up [1–3]. While digital health presents significant promise in these settings, scaling such innovations remains a persistent challenge due to systemic fragmentation, limited regulatory clarity, […]
Chronic respiratory diseases (CRDs), which include chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, interstitial lung disease (ILD), post-tuberculosis (post-TB), and lung cancer survivors, contribute to 7.4% of the global disease burden [1]. People with CRDs experience disabling symptoms such as breathlessness, reduced exercise intolerance, cough, and poor quality of life. Pulmonary rehabilitation (PR), a comprehensive […]
Governments worldwide responded to the continual waves of the COVID-19 pandemic with unprecedented measures ranging from social distancing and cancellation of public events to border restrictions and complete closure of all but essential services [1]. Health research studies were suspended, becoming casualties of COVID-19-related lockdowns and distancing policies [2]. Engaging and involving stakeholders including patients, […]
In the context of global health research, stakeholder engagement is an iterative process where researchers actively seek the knowledge and experience of individuals or groups that are interested in, or impacted by, a disease, a health condition or an intervention. In doing so, they enable these stakeholders, including patients, public, community leaders, health workers, health […]
Chronic obstructive pulmonary disease (COPD) is a prevalent and growing global health issue, driven primarily by factors such as smoking and exposure to biomass fumes [1,2]. It significantly impacts morbidity and mortality rates, and despite advancements in management, no curative treatment exists. Approximately 400 million people worldwide are affected by COPD, with 80% residing in […]